111 related articles for article (PubMed ID: 27159935)
1. Canadian Palliative Community Milrinone Infusions: A Case Series.
Reimche R; Salcedo D
Can J Cardiovasc Nurs; 2016; 26(1):9-13. PubMed ID: 27159935
[TBL] [Abstract][Full Text] [Related]
2. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
Curley M; Liebers J; Maynard R
J Infus Nurs; 2017; 40(2):92-96. PubMed ID: 28248808
[TBL] [Abstract][Full Text] [Related]
3. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
Felker GM; Benza RL; Chandler AB; Leimberger JD; Cuffe MS; Califf RM; Gheorghiade M; O'Connor CM;
J Am Coll Cardiol; 2003 Mar; 41(6):997-1003. PubMed ID: 12651048
[TBL] [Abstract][Full Text] [Related]
4. Infusion therapy with milrinone in the home care setting for patients who have advanced heart failure.
Boger JE; DeLuca SL; Watkins DF; Vershave KK; Thomley AM
J Intraven Nurs; 1997; 20(3):148-54. PubMed ID: 9214927
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
Brozena SC; Twomey C; Goldberg LR; Desai SS; Drachman B; Kao A; Popjes E; Zimmer R; Jessup M
J Heart Lung Transplant; 2004 Sep; 23(9):1082-6. PubMed ID: 15454175
[TBL] [Abstract][Full Text] [Related]
6. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
López-Candales AL; Carron C; Schwartz J
Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
[TBL] [Abstract][Full Text] [Related]
7. Intravenous milrinone infusion improves congestive heart failure caused by diastolic dysfunction: a brief case series.
Albrecht CA; Giesler GM; Kar B; Hariharan R; Delgado RM
Tex Heart Inst J; 2005; 32(2):220-3. PubMed ID: 16107121
[TBL] [Abstract][Full Text] [Related]
8. Use and Discontinuation of Milrinone for Advanced Heart Failure in an Academic Palliative Care Unit: A Case Report and Discussion of Recommendations.
Wolfe A; Watt CL; Downar J; Bush SH
J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):24-33. PubMed ID: 35234559
[TBL] [Abstract][Full Text] [Related]
9. Intravenous heart failure medications: an update for home health clinicians.
Sherrod MM; Graulty R; Crawford M; Cheek DJ
Home Healthc Nurse; 2009; 27(10):610-9; quiz 620-1. PubMed ID: 19907237
[TBL] [Abstract][Full Text] [Related]
10. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
Malotte K; Saguros A; Groninger H
J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
[TBL] [Abstract][Full Text] [Related]
11. Continuous milrinone infusion during preoperative anti-inflammatory therapy in inflammatory aortic aneurysm complicating severe congestive heart failure.
Takeno M; Takagi S; Sakuragi S; Suzuki S; Tsutsumi Y; Nonogi H; Goto Y
Heart Vessels; 2002 Nov; 17(1):42-4. PubMed ID: 12434201
[TBL] [Abstract][Full Text] [Related]
12. Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit.
Silvestre J; Montoya M; Bruera E; Elsayem A
Palliat Support Care; 2015 Dec; 13(6):1781-5. PubMed ID: 25908519
[TBL] [Abstract][Full Text] [Related]
13. Chronic heart failure and the quality of life.
Pritzker MR
N Engl J Med; 1999 May; 340(19):1511; author reply 1512. PubMed ID: 10328720
[No Abstract] [Full Text] [Related]
14. Hospital in the home.
Montalto M
Aust Fam Physician; 2011 Apr; 40(4):183, 185. PubMed ID: 21744523
[No Abstract] [Full Text] [Related]
15. Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone?
Haglund NA; Cox ZL; Lee JT; Song Y; Keebler ME; DiSalvo TG; Maltais S; Lenihan DJ; Wigger MA
J Card Fail; 2014 Sep; 20(9):630-7. PubMed ID: 24954426
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
[TBL] [Abstract][Full Text] [Related]
17. [Heart function and clinical observations of patients with severe congestive heart failure treated with milrinone].
Lu G; Zheng Z; Zhang L
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):27-9. PubMed ID: 10322703
[TBL] [Abstract][Full Text] [Related]
18. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
[TBL] [Abstract][Full Text] [Related]
19. Pharmacy Support of a Pediatric Patient Receiving Milrinone at Home.
Xue A; Dersch-Mills D; Tsang C; Greenway SC
Can J Hosp Pharm; 2016; 69(5):415-419. PubMed ID: 27826160
[No Abstract] [Full Text] [Related]
20. Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure.
Lanfear DE; Hasan R; Gupta RC; Williams C; Czerska B; Tita C; Bazari R; Sabbah HN
J Transl Med; 2009 Jul; 7():67. PubMed ID: 19640280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
